<ARTICLE> 5 <LEGEND> THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE CONSOLIDATED STATEMENT OF OPERATIONS AND BALANCE SHEET OF ALLERGAN, INC. </LEGEND> <MULTIPLIER> 1,000 <PERIOD-TYPE> 3-MOS <FISCAL-YEAR-END> DEC-31-1999 <PERIOD-START> JAN-01-1999 <PERIOD-END> MAR-26-1999 <CASH> 209,500 <SECURITIES> 0 <RECEIVABLES> 210,300 <ALLOWANCES> 8,000 <INVENTORY> 126,500 <CURRENT-ASSETS> 664,700 <PP&E> 590,600 <DEPRECIATION> 274,000 <TOTAL-ASSETS> 1,316,400 <CURRENT-LIABILITIES> 352,300 <BONDS> 195,500 <PREFERRED-MANDATORY> 0 <PREFERRED> 0 <COMMON> 700 <OTHER-SE> 695,300 <TOTAL-LIABILITY-AND-EQUITY> 1,316,400 <SALES> 311,300 <TOTAL-REVENUES> 321,100 <CGS> 89,700 <TOTAL-COSTS> 98,800 <OTHER-EXPENSES> 0 <LOSS-PROVISION> 300 <INTEREST-EXPENSE> 3,300 <INCOME-PRETAX> 50,700 <INCOME-TAX> 15,700 <INCOME-CONTINUING> 35,000 <DISCONTINUED> 0 <EXTRAORDINARY> 0 <CHANGES> 0 <NET-INCOME> 35,000 <EPS-PRIMARY> 0.53 <EPS-DILUTED> 0.51